Form 8-K - Current report:
SEC Accession No. 0000950170-24-123718
Filing Date
2024-11-08
Accepted
2024-11-08 08:49:19
Documents
15
Period of Report
2024-11-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K iron-20241106.htm   iXBRL 8-K 50832
2 EX-10.1 iron-ex10_1.htm EX-10.1 1118233
3 EX-99.1 iron-ex99_1.htm EX-99.1 20969
4 GRAPHIC img57926557_0.jpg GRAPHIC 19414
5 GRAPHIC img57926557_1.jpg GRAPHIC 19414
  Complete submission text file 0000950170-24-123718.txt   1516131

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT iron-20241106.xsd EX-101.SCH 25843
17 EXTRACTED XBRL INSTANCE DOCUMENT iron-20241106_htm.xml XML 4883
Mailing Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472
Business Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472 (617) 674-9274
Disc Medicine, Inc. (Filer) CIK: 0001816736 (see all company filings)

EIN.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39438 | Film No.: 241438146
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)